Vertex Pharmaceuticals Incorporated (FRA:VX1)
445.85
+5.75 (1.31%)
At close: Apr 30, 2025, 10:00 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €113.73 billion as of May 2, 2025. Its market cap has increased by 17.74% in one year.
Market Cap
113.73B
Enterprise Value
105.33B
Revenue
10.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
€445.85
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 113.73B, an increase of 153,831.47%. That is a compound annual growth rate of 24.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 297.83B |
Siemens Aktiengesellschaft | 157.90B |
Deutsche Telekom AG | 154.34B |
Allianz SE | 140.11B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 78.59B |
Rheinmetall AG | 65.11B |
Siemens Energy AG | 55.12B |
Merck KGaA | 53.00B |